SearchDictionaryMobileLogin

Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease).

AuthorsC Voigtländer, M Lüftl, G Schuler, M Hertl (Affiliation: Department of Dermatology, University of Erlangen-Nürnberg, Erlangen, Germany.)
JournalArchives of dermatology (Arch Dermatol) Vol. 137 Issue 12 Pg. 1571-4 (Dec 2001) ISSN: 0003-987X United States
PMID11735706 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • infliximab
  • C-Reactive Protein
Topics
  • Aged
  • Antibodies, Monoclonal (administration & dosage, therapeutic use)
  • Arm
  • Breast Neoplasms (surgery)
  • C-Reactive Protein
  • Dermatologic Agents (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Infusions, Intravenous
  • Leukocyte Count
  • Skin Diseases, Vesiculobullous (drug therapy)
  • Thorax
  • Tumor Necrosis Factor-alpha